china

Fangzhous XingJie LLM Completes Key National Filing, Setting Stage for Further AI-Driven Chronic Care Innovations

SHENZHEN, China, Nov. 02, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leader in AI-driven…

2 months ago

LUMOSA THERAPEUTICS ANNOUNCES POSITIVE RESULTS FROM LT3001(INTRAVENOUS ODATROLTIDE) PHASE 2B CLINICAL TRIAL IN ACUTE ISCHEMIC STROKE

Results presented at the 17th World Stroke Congress (WSC 2025) LT3001(Odatroltide)-202 phase 2b study met primary endpoint. No symptomatic intracranial…

2 months ago

World Cities Day 2025: Zoomlion Bolsters Global Urban Development, Focusing on People-Centered Smart Cities

CHANGSHA, China, Oct. 31, 2025 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion"; 1157.HK) is marking World…

2 months ago

Beijing’s Timeless Charm Goes Global

BEIJING, Oct. 31, 2025 /PRNewswire/ -- The 2025 Overseas Promotion of the Charming Beijing TV series is a cultural exchange initiative…

2 months ago

China Pioneers Urban Health-Climate Solutions as Risks Hit Record High, Offers New Pathways for Global South

The new Lancet Countdown China report reveals that 8 of 13 climate-health risk indicators are at historic peaks; the Beijing…

2 months ago

Sinopec and BASF Mutually Recognize Product Carbon Footprint Accounting Methods, Sets New Benchmark for Industry Standardization

NINGBO, China, Oct. 31, 2025 /PRNewswire/ -- China Petroleum & Chemical Corporation (HKG: 0386, "Sinopec") and BASF jointly declared the alignment…

2 months ago

CGTN: How China champions openness and multilateralism to build Asia-Pacific community

During the 32nd APEC Economic Leaders' Meeting in Gyeongju, CGTN published an article highlighting how Chinese President Xi Jinping's engagement…

2 months ago

SERES Net Profit for First Three Quarters Hits 5.312 Billion RMB, to Be the First Luxury NEV Maker with “A+H” Listing

CHONGQING, China, Oct. 31, 2025 /PRNewswire/ -- On October 30, SERES released its financial results for the third quarter of 2025.…

2 months ago

ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection

SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II…

2 months ago

Xinhua Silk Road: 2025 Chishui River Forum held in Guizhou, SW. China

BEIJING, Oct. 30, 2025 /PRNewswire/ -- The 2025 Chishui River Forum was held in Maotai Town of Renhuai City in southwest…

2 months ago